State Street Corp Acquires 8,344 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

State Street Corp increased its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 0.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,410,543 shares of the construction company’s stock after buying an additional 8,344 shares during the quarter. State Street Corp’s holdings in Aspen Aerogels were worth $39,058,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Point72 Hong Kong Ltd bought a new position in Aspen Aerogels in the 2nd quarter valued at approximately $84,000. nVerses Capital LLC purchased a new position in shares of Aspen Aerogels in the second quarter worth $95,000. Quent Capital LLC bought a new position in shares of Aspen Aerogels during the third quarter valued at $118,000. Point72 DIFC Ltd purchased a new stake in shares of Aspen Aerogels during the second quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado bought a new stake in Aspen Aerogels in the 2nd quarter worth about $145,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Up 0.5 %

NYSE:ASPN opened at $12.05 on Friday. Aspen Aerogels, Inc. has a twelve month low of $10.75 and a twelve month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market cap of $988.67 million, a PE ratio of 1,206.21 and a beta of 2.11. The company’s 50 day moving average is $16.32 and its two-hundred day moving average is $22.39.

Analysts Set New Price Targets

ASPN has been the topic of a number of recent analyst reports. Piper Sandler dropped their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Roth Mkm reduced their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Finally, HC Wainwright reissued a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $28.70.

Insider Activity

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.